Tenapanor improves symptoms in IBS-C

May 15, 2017
Tenapanor, an investigational, minimally systemic, small-molecule NHE3 inhibitor, was well tolerated and improved symptoms in patients with…

Meeting NewsVideo

VIDEO: Older age, more severe IBS linked to relapse after treatment with Xifaxan

May 12, 2017
CHICAGO — In this exclusive video from Digestive Disease Week, Mark Pimentel, MD, executive director of the Medically Associated Science and…

Meeting News

Trulance improves symptoms in patients with IBS-C

May 11, 2017
CHICAGO — Trulance safely and effectively improved symptoms in patients with constipation-predominant irritable bowel syndrome, according to…

Meeting News

Low FODMAPs diet safe, effective under guide of expert nutritionist

May 8, 2017
CHICAGO — Researchers found that while a low FODMAP diet is safe and effective in patients with irritable bowel syndrome, patients were often…

Meeting NewsPerspective

FMT improves symptoms, QOL in IBS patients

May 8, 2017
CHICAGO — Fecal microbiota transplantation improved symptoms and quality of life in patients with irritable bowel syndrome, according to the…

Meeting News

Older age, more symptoms prompt people with IBS to seek care

May 7, 2017
CHICAGO — Individuals with irritable bowel syndrome in the general population are more likely to seek medical care if they are older, more…

Meeting News

Antigliadin antibodies may indicate gluten-free diet will help in IBS

May 7, 2017
CHICAGO — Antigliadin antibodies may be a useful biomarker for predicting which patients with irritable bowel syndrome will improve on a…

In the Journals

Researchers question quality of data supporting low FODMAP diet in IBS

April 27, 2017
Randomized controlled trials of the low FODMAP diet for irritable bowel syndrome carry a high risk for bias and have insufficient follow-up, and the…

In the Journals

Hypnosis CDs noninferior to hypnotherapist for children with IBS, functional abdominal pain

April 18, 2017
Home-based hypnotherapy exercises on a CD were as effective as individual gut-directed hypnotherapy performed by a qualified therapist in children…

8 news updates to mark IBS Awareness Month

April 14, 2017
April is IBS Awareness Month, first designated by the International Foundation for Functional Gastrointestinal Disorders in 1997 to spread awareness…

New 'all-in-one' blood, stool test helps diagnose common causes of persistent diarrhea

April 3, 2017
Prometheus Laboratories has announced the launch of a new test called IBcause that simultaneously evaluates 20 stool and serum measures to help…

FDA News

Synergy submits sNDA for CIC drug Trulance to treat IBS-C

March 28, 2017
Synergy Pharmaceuticals announced it has submitted a supplemental New Drug Application to the FDA for Trulance for the treatment of adults with…

FDA News

FDA warns IBS drug Viberzi may cause severe pancreatitis in patients without gallbladder

March 16, 2017
The FDA has issued a safety announcement warning that Viberzi should not be used in patients who do not have a gallbladder due to an increased risk…

In the Journals

Many people with IBS-D symptoms remain undiagnosed

March 3, 2017
Symptoms related to diarrhea-predominant irritable bowel syndrome significantly impact quality of life, yet a substantial proportion of individuals…

In the Journals

Acupuncture significantly benefits IBS patients through 1 year, benefits minimized at 2 years

February 27, 2017
Acupuncture improved symptoms in patients with irritable bowel syndrome that were statistically superior to standard of care through 1 year, but…

In the Journals

Gut microbiome marker linked to IBS severity

January 30, 2017
Researchers have identified an intestinal microbiota signature associated with severity of symptoms in irritable bowel syndrome. Using a…

Clinical trial in IBS begins for cannabis-based chewing gum

January 20, 2017
Axim Biotechnologies has initiated a clinical trial of its non-prescription hemp-derived cannabinoid functional chewing gum for the treatment of…

Perspective

Federal report: Evidence lacking on effectiveness of cannabis for IBS

January 13, 2017
Evidence on the effectiveness of cannabis and cannabinoids for the treatment of irritable bowel syndrome is insufficient, and represents a…

Allergan acquires rights to Assembly's microbiome development programs in IBD, IBS

January 11, 2017
Allergan has entered a research, development, collaboration and license agreement for global rights to Assembly Bioscience’s GI microbiome…

In the Journals

Functional abdominal pain disorders common in children with IBD

January 4, 2017
More than a quarter of children with inflammatory bowel disease had an overlapping functional abdominal pain disorder in a recent study. Further…